- Home
- ACRV vs USIO Comparison
ACRV vs USIO Comparison
Compare ACRV & USIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- USIO
- Stock Information
- Founded
- ACRV 2018
- USIO 1998
- Country
- ACRV United States
- USIO United States
- Employees
- ACRV N/A
- USIO N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- USIO Investment Bankers/Brokers/Service
- Sector
- ACRV Health Care
- USIO Finance
- Exchange
- ACRV Nasdaq
- USIO Nasdaq
- Market Cap
- ACRV 40.4M
- USIO 47.7M
- IPO Year
- ACRV 2022
- USIO N/A
- Fundamental
- Price
- ACRV $1.26
- USIO $1.68
- Analyst Decision
- ACRV Buy
- USIO Strong Buy
- Analyst Count
- ACRV 7
- USIO 1
- Target Price
- ACRV $17.60
- USIO $4.00
- AVG Volume (30 Days)
- ACRV 287.7K
- USIO 83.5K
- Earning Date
- ACRV 08-12-2025
- USIO 08-06-2025
- Dividend Yield
- ACRV N/A
- USIO N/A
- EPS Growth
- ACRV N/A
- USIO N/A
- EPS
- ACRV N/A
- USIO 0.12
- Revenue
- ACRV N/A
- USIO $83,970,504.00
- Revenue This Year
- ACRV N/A
- USIO $16.02
- Revenue Next Year
- ACRV $1,037.93
- USIO $13.24
- P/E Ratio
- ACRV N/A
- USIO $14.04
- Revenue Growth
- ACRV N/A
- USIO 0.46
- 52 Week Low
- ACRV $1.05
- USIO $1.24
- 52 Week High
- ACRV $10.16
- USIO $2.92
- Technical
- Relative Strength Index (RSI)
- ACRV 43.05
- USIO 50.57
- Support Level
- ACRV $1.34
- USIO $1.72
- Resistance Level
- ACRV $1.48
- USIO $1.83
- Average True Range (ATR)
- ACRV 0.10
- USIO 0.09
- MACD
- ACRV -0.01
- USIO -0.02
- Stochastic Oscillator
- ACRV 17.24
- USIO 18.27
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About USIO Usio Inc.
Usio Inc is a United States-based company that provides integrated electronic payment services, including credit and debit card-based processing services and transaction processing via the Automated Clearing House, or ACH network to billers and retailers. The Company also has an additional wholly-owned subsidiary, which is the entity for Output Solutions operations.